Home » Topics » Regulatory

Regulatory
RSS

New Adderall XR approval extends use to adolescents

July 26, 2005

Rozerem receives FDA approval for insomnia

July 26, 2005

Retisert launched for chronic noninfectious uveitis

July 6, 2005

New approval for Topamax

July 5, 2005

Avelox approved for complicated skin and skin structure infections

July 1, 2005

BiDil approved for treatment of heart failure in black patients

June 28, 2005

Accelerated approval for Aptivus in HIV

June 23, 2005

Tygacil receives FDA approval

June 17, 2005

Enbrel approved to improve physical function in psoriatic arthritis

June 2, 2005

FDA approval for Naglazyme

June 2, 2005